Use the Back button in your browser to see the other results of your search or to select another record.
| Comparison of the effectiveness of extensor muscle strengthening exercise by itself, exercise with polydeoxyribonucleotide injection, and exercise with extracorporeal shockwave therapy in lateral epicondylitis: a randomized controlled trial | 
| Shim BJ, Seo E-M, Hwang J-T, Kim D-Y, Yang J-S, Seo S-J, Hong MS | 
| Clinics in Shoulder and Elbow 2021 Dec;24(4):231-238 | 
| clinical trial | 
| 7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* | 
| BACKGROUND: Extensor muscle strengthening exercises with counterforce braces (EX) is a conventional conservative treatment for lateral epicondylitis (LE) of the elbow. In addition, polydeoxyribonucleotide (PDRN) or extracorporeal shockwave therapy (ESWT) has been recently used for LE. METHODS: Sixty-three patients with chronic LE participated in this study and randomly allocated in three groups (G1 EX, G2 EX plus PDRN injection, and G3 EX+ESWT). All of the three groups were taught to perform EX at the first out-patient department (OPD) visit. Group 2 was injected with 3 mL PDRN (5.625 mg/3 mL), while group 3 received ESWT at the first OPD visit. Visual analog scale pain score, Mayo elbow performance score (MEPS), and ultrasonographic examination were checked before, 6 weeks, and 12 weeks after the treatments. RESULTS: Overall functional scores and ultrasonographic findings in all three groups improved after treatment. The mean MEPS in group 2 improved more than groups 1 and 3 at 6 weeks (G1 56.9 > 62.4; G2 54.3 > 65.0; G3 55.7 > 62.6), and more than group 1 at 12 weeks (G1 56.9 > 67.9; G2 54.3 > 73.6). The mean common extensor tendon depth (CETD) on ultrasonography in group 2 increased more than groups 1 and 3 at 6 and 12 weeks (6 weeks G1 0.385 > 0.386; G2 0.332 > 0.392; G3 0.334 > 0.357; 12 weeks G1 0.385 > 0.409; G2 0.332 > 0.438; G3 0.334 > 0.405 cm). CONCLUSIONS: PDRN injections combined with EX exhibited a greater improvement in mean MEPS and mean CETD compared to EX only or EX combined with ESWT for LE within the 12 weeks follow-up.  
 |